CCL2 and Hepatic steatosis: Inhibition of TNF-α expression in a murine model resulted in significantly reduced hepatic steatosis and fibrosis, together with decreased expression of MCP-1, TGF-β, Col1a1 and metallopeptidase inhibitor 1 [65].